Showing 39,701 - 39,720 results of 103,744 for search '(( e point decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.68s Refine Results
  1. 39701
  2. 39702
  3. 39703
  4. 39704
  5. 39705
  6. 39706

    pHI for net status. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  7. 39707

    Combined net integrity PBO and LLINs-PLOS1. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  8. 39708

    Factors affecting pyrethroid-LLINs integrity. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  9. 39709

    Factors associated with mosquito net integrity. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  10. 39710

    LLINs knockdown performance over time. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  11. 39711

    Factors affecting PBO-LLINs integrity. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  12. 39712

    Net bioefficacy data. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  13. 39713

    House structure and status. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  14. 39714

    LLINs hole positions over time. by Job Oyweri (22041452)

    Published 2025
    “…Against the Kisumu susceptible <i><i>Anopheles gambiae</i></i> s.s, both net types decreased in mortality at baseline (when new) from 97.6% to 18.4% and 98.6% to 18.5% for pyrethroid and PBO-LLINs respectively at 18 months. …”
  15. 39715

    Timeline of BBB closing for a single low-pressure sonication depicted in Figure 10. by Fabrice Marquet (347674)

    Published 2014
    “…The total volume of opened voxels decreases as a function of time from the sonication. …”
  16. 39716
  17. 39717

    Minimally Invasive Valve Sparing Aortic Root Replacement in a Patient With Marfan Syndrome by Oleg Orlov (4059448)

    Published 2018
    “…</div><div><p>Preoperative computed tomography of the chest showed an aortic root dilatation at the sinuses of Valsalva, which measured 5.5 cm. Transesophageal echocardiogram (TEE) demonstrated a trileaflet aortic valve with moderate aortic valve insufficiency. …”
  18. 39718

    Nick closing activity of <i>w</i>Bm-LigA and biochemical characterization. by Nidhi Shrivastava (315987)

    Published 2013
    “…<p>(A) Effect of enzyme substrate ratio on nick closing activity. …”
  19. 39719

    SPARC improves cardiomyocyte function in a mild model of virus-induced heart failure. by Sophie Deckx (800206)

    Published 2019
    “…This results in moderate cardiac inflammation after 1 week), little fibrosis and no cardiomyocyte hypertrophy after 5 weeks. E,F Viral infection caused decreased FS and increased ESD. …”
  20. 39720